(Q46595066)

23 December 2017

title

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients (English)

1 reference

23 December 2017

0 references

R H B Benedict

1

1 reference

23 December 2017

F Munschauer

2

1 reference

23 December 2017

P Zarevics

3

1 reference

23 December 2017

D Erlanger

4

1 reference

23 December 2017

V Rowe

5

1 reference

23 December 2017

T Feaster

6

1 reference

23 December 2017

R L Carpenter

7

1 reference

23 December 2017

publication date

16 May 2008

1 reference

23 December 2017

published in

Journal of Neurology

1 reference

23 December 2017

volume

255

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

848-852

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7

exact match

0 references

cites work

Minimal neuropsychological assessment of MS patients: a consensus approach

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0760-7

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0760-7

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0760-7

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-0760-7

Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?

21 January 2018

1 reference

12 December 2020

Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy.

1 reference

12 December 2020

1 reference

12 December 2020

Neuroscience of addiction

1 reference

12 December 2020

Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex

1 reference

12 December 2020

Differences in some behavioural effects of deprenyl and amphetamine enantiomers in rats.

1 reference

12 December 2020

The nature of memory impairments in multiple sclerosis: acquisition versus retrieval.

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis: a review of recent developments

1 reference

12 December 2020

Behavioral characterization of d- and l-amphetamine: neurochemical implications

1 reference

12 December 2020

Effect of amphetamine on long-term retention of verbal material.

1 reference

12 December 2020

Treatment of attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Modafinil affects mood, but not cognitive function, in healthy young volunteers

1 reference

12 December 2020

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

1 reference

12 December 2020

Stimulus properties of d-amphetamine as compared to 1-amphetamine

1 reference

12 December 2020

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

1 reference

12 December 2020

Evaluation of physical dependence liability of l-deprenyl (selegiline) in animals

1 reference

12 December 2020

10.1007/S00415-008-0760-7

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017